Psiachou-Leonard E, Bain B J
Department of Haematology, St Mary's Hospital, London, UK.
Clin Lab Haematol. 1998 Jun;20(3):195-7. doi: 10.1046/j.1365-2257.1998.00118.x.
Myelodysplastic syndromes (MDS) have rarely been reported after treatment with nucleoside analogues, and mainly in patients who have also received alkylating agents. We report a patient who developed MDS (refractory anaemia with ring sideroblasts) after treatment with pentostatin (deoxycoformycin) alone.
核苷类似物治疗后很少有骨髓增生异常综合征(MDS)的报道,且主要见于同时接受过烷化剂治疗的患者。我们报告了1例单独接受喷司他丁(脱氧助间型霉素)治疗后发生MDS(伴有环形铁粒幼细胞的难治性贫血)的患者。